Clinical Trial Update: A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating LY3972406 in adults with moderate-to-severe plaque psoriasis has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• LY3972406

Snippet

Sponsor: Eli Lilly and Company | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2025-10-15